Salesforce, Inc. (CRM) — RQD Stock Rating Cockpit
Salesforce, Inc. (CRM) earns a Roarable Rating of B- (Buy) with 69/100 RQD Confidence. Multiple CRM insiders deployed $27.5M of their own cash alongside 77% profit margin. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
Decent core business (77% profit margin), though cash flow growth is moderate rather than explosive right now.
Multiple company executives/directors just spent their own personal cash to buy shares on the open market.
No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.
2-of-3 JEV AI Jury Bullish on CRM
9.9% ROIC with 77.3% gross margin and 8.03% FCF yield.
Altman-Z 2.55 and Piotroski 7/9 pass balance-sheet audit.
Put/Call 1.08x with 28/40 institutional & insider flow.
- ✓Company leadership has skin in the game with net positive insider conviction.
- ✓Clean SEC annual filing review with no major hidden accounting time-bombs.
- !Sensitive to high interest rates and tighter Federal Reserve market liquidity.
Whale Flow & Momentum Playbook: Trading CRM & AI Leaders Without Chasing Tops
- ✓Exact institutional whale strikes & implied earnings range on CRM this week
- ✓How active traders scale setups using funded prop-firm accounts instead of risking savings
- ✓Free bonus: instant RQD Rating Flip alerts on all tracked momentum leaders
CRM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
SEC XBRL FY2024 → FY2025: Net share cannibal / buyback tailwind.
vs. +11.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CRM today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CRM. Explore sector supply chains on /butterfly.
CRM Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDShould I buy, hold, or sell CRM stock right now?
Salesforce, Inc. (CRM) currently earns a Roarable Rating of B- (Buy — BUY) with 69/100 RQD Confidence. Multiple CRM insiders deployed $27.5M of their own cash alongside 77% profit margin.
What is CRM's 12-month price target and RQD AI Jury consensus?
CRM's 12-month base price target is $272.06 (range $246.53 to $290.07), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.